Federal indictment targets Houston transplant surgeon over alleged medical-record alterations that made patients ineligible for organs
Indictment centers on alleged false statements tied to transplant eligibility changes
A Houston transplant surgeon who previously led an abdominal transplant program has been indicted on federal charges accusing him of falsifying medical information in ways that could affect whether patients qualify to receive donor organs.
The indictment alleges the physician made false statements in health care matters and altered records tied to transplant decision-making. Prosecutors say the changes had the effect of making certain patients ineligible for transplantation—without the patients, and in some instances their broader care teams, being aware of the modifications at the time.
What investigators say happened inside transplant listing systems
At the center of the case are allegations that the surgeon changed transplant-related entries used to determine donor acceptance criteria and patient status on the waiting list. Those entries can include thresholds such as donor age and weight ranges and other parameters that influence whether an offered organ is considered acceptable for a particular patient.
Regulatory and court records described in reporting on the case indicate that the physician allegedly adjusted criteria in a way that inactivated multiple patients on a national transplant database, effectively removing them from active consideration for organs unless and until the listing was restored.
An indictment is a formal accusation. The defendant is presumed innocent unless and until proven guilty beyond a reasonable doubt.
Institutional fallout: paused transplants, oversight actions, leadership changes
The alleged conduct surfaced publicly in spring 2024, triggering operational disruption and external scrutiny. The hospital system involved halted portions of its abdominal transplant activity and transferred affected patients while internal reviews and oversight processes proceeded. The transplant program later resumed operations after implementing procedural changes intended to prevent unilateral alterations to key listing fields.
Separate oversight actions also affected the institution’s standing within the national transplant network, increasing scrutiny of compliance practices and governance. The hospital subsequently announced a new leader for the abdominal transplant program.
Related civil litigation points to patient harm claims
A wrongful death lawsuit filed by the family of one former patient alleges that transplant eligibility changes contributed to delays in receiving an organ and worsened the patient’s condition. The lawsuit also alleges that donor acceptance settings were repeatedly revised in ways inconsistent with typical transplant listing practices. Civil claims remain separate from the criminal case and carry different legal standards.
What happens next
The physician has faced initial steps in the federal criminal process, including surrender and a scheduled court appearance, as the case moves through pretrial proceedings. The charges focus on alleged false statements and documentation related to health care matters; any determination about intent, responsibility, and patient impact will be made through court findings and adjudication.
Federal prosecutors must prove the charged conduct beyond a reasonable doubt.
Hospitals and transplant programs remain subject to ongoing oversight requirements designed to ensure accurate listing practices and transparent patient notification.
Patients affected by listing changes may pursue separate civil remedies, which are decided independently from criminal proceedings.